Lourdes R. Reynolds, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 620 S Haynes Ave, Miles City, MT 59301 Phone: 406-238-2500 |
Mrs. Patricia June Pezzarossi, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 210 S Winchester Ave, 136, Miles City, MT 59301 Phone: 406-234-8793 Fax: 406-234-8796 |
Dr. Steven James Griffin, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 2600 Wilson St, Miles City, MT 59301 Phone: 406-233-2600 |
James E. Young, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 620 S Haynes Ave, Miles City, MT 59301 Phone: 406-233-7000 |
Patrick G. Williams, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 620 S Haynes Ave, Miles City, MT 59301 Phone: 406-233-7000 |
News Archive
The day a person is diagnosed with cancer is one of the most difficult days of his or her life. While the Internet holds an endless supply of cancer related information, for an overwhelmed and frightened person, genuine emotional support is often hard to find. TheDayIFoundOut(TM) is an online community featuring the faces and voices of cancer survivors offering empathy, insight, advice and resources to help cancer patients take the first crucial steps toward beating their disease.
Over 20 million people in the United States take beta-blockers, a medication commonly prescribed for cardiovascular issues, anxiety, hypertension and more. Many of these same people also have trouble sleeping, a side effect possibly related to the fact that these medications suppress night-time melatonin production. Researchers at Brigham and Women's Hospital (BWH) have found that melatonin supplementation significantly improved sleep in hypertensive patients taking beta-blockers.
Prisoners need education on the appropriate use of topical antibiotic products, according to a study released today at the 39th Annual Educational Conference and International Meeting of the Association for Professionals in Infection Control and Epidemiology.
Advanced imaging with Positron Emission Tomography (PET) scan shows great promise in predicting which patients with inoperable lung cancer have more aggressive tumors and need additional treatment following standard chemotherapy/radiation therapy, according to new research recently published online in the Journal of Clinical Oncology.
› Verified 4 days ago